female androgenetic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: In the case group, patients undergoing mesotherapy with microneedling with a solution of 20 mg of biotin + 500 mg of dexpanthenol per month plus topical minoxidil 2
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Having a female pattern hair loss Do not use other hair loss treatments at the time of enrollment Do not use temporary and permanent hair dye and curl or straighten hair Do not use aspirin, warfarin, steroids, oral retinoids, hormones or cytotoxic drugs Absence of pregnancy and lactation Absence of high androgenic blood levels, irregular periods, acne and hirsutism, thromboembolic events, low ferritin blood levels and impaired TSH
Exclusion criteria
Exclusion criteria: Allergic reaction to the drug used Failure to complete the course of treatment and failure to refer for follow-up, which results in a drawing on the case file or the patient Local reactions such as abscesses, inflammation and cellulite at the injection site The patient's decision not to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appearance based on photography. Timepoint: Photographs will be taken first before the start of treatment and finally two weeks after the microneedling sessions. Method of measurement: By a dermatologist.;Intensity based on Ludwig Griding. Timepoint: It is performed before treatment and at 18 weeks by a dermatologist who is unaware of the patient's grouping. Method of measurement: By a dermatologist.;Number of hairs plucked in the hair pulling test. Timepoint: The number of hairs removed before treatment and after 18 weeks is counted and recorded. Method of measurement: In the hair pull test, about 20-30 hairs in the vortex area between the thumb and the other 4 fingers are gently pulled and pulled vertically.;Patient opinion about density, thickness, hair loss and quality. Timepoint: before and after the treatment. Method of measurement: In the self-assessment of the patient, the result of the treatment is asked about increasing hair density, increasing hair thickness, hair loss rate and hair quality (color and transparency). Answers are considered as worsening 1-, without changing 0 and improving 1. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications. Timepoint: In each session. Method of measurement: Complications of treatment in each session, including headache, cramping, itching, ecchymosis, puffy eyes, increased hair growth in other parts of the body and changes in menstrual patterns, patients are asked and recorded. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZakiye Ganjei
Esfahan University of Medical Sciences
Outcome results
None listed